HUMACYTE INC. - WARRA
1.8620
08-October-24 11:27:37
15 minutes delayed
Stocks
-0.0056
-0.30%
Today's range
1.8500 - 2.0001
ISIN
N/A
Source
NASDAQ
-
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.1% Following Analyst Downgrade
08 Oct 2024 11:31:10 By Buzz FX
-
Vertiv (NYSE:VRT) Trading 0.1% Higher After Analyst Upgrade
08 Oct 2024 11:31:10 By Buzz FX
-
PepsiCo (NASDAQ:PEP) Shares Up 0.7% After Better-Than-Expected Earnings
08 Oct 2024 11:31:10 By Buzz FX
-
Rising Yields And Higher Neutral Rate May Spoil The Party, Biggest Stock Moves In Years Ahead
08 Oct 2024 11:20:17 By Buzz FX
-
Robinhood Markets (NASDAQ:HOOD) Stock Price Up 5.3% on Analyst Upgrade
08 Oct 2024 11:07:11 By Buzz FX
-
Scholar Rock (NASDAQ:SRRK) Sees Strong Trading Volume After Analyst Upgrade
08 Oct 2024 11:06:09 By Buzz FX
-
Parsons (NYSE:PSN) Hits New 1-Year High on Analyst Upgrade
08 Oct 2024 11:06:09 By Buzz FX
-
Allegion (NYSE:ALLE) Hits New 12-Month High After Analyst Upgrade
08 Oct 2024 11:06:09 By Buzz FX
-
ServiceNow (NYSE:NOW) Shares Gap Up on Analyst Upgrade
08 Oct 2024 11:06:09 By Buzz FX
-
Duckhorn Portfolio (NYSE:NAPA) Sees Large Volume Increase Following Strong Earnings
08 Oct 2024 11:06:09 By Buzz FX
-
Solana Falls More Than 4% In 24 hours
08 Oct 2024 11:05:17 By Buzz FX
-
Shiba Inu Falls More Than 4% In 24 hours
08 Oct 2024 11:05:17 By Buzz FX
-
Chainlink Down More Than 4% Within 24 hours
08 Oct 2024 11:05:17 By Buzz FX
-
Dogecoin Decreases More Than 5% Within 24 hours
08 Oct 2024 11:05:17 By Buzz FX
-
Equifax (NYSE:EFX) PT Raised to $315.00 | MarketBeat
08 Oct 2024 11:01:11 By Buzz FX
-
Citigroup Boosts Altria Group (NYSE:MO) Price Target to $48.00
08 Oct 2024 11:01:11 By Buzz FX
-
The Goldman Sachs Group Trims Maravai LifeSciences (NASDAQ:MRVI) Target Price to $7.00
08 Oct 2024 11:01:11 By Buzz FX
-
UFP Industries (NASDAQ:UFPI) Upgraded to Outperform by Wedbush
08 Oct 2024 11:01:11 By Buzz FX
-
LandBridge (NYSE:LB) Price Target Increased to $43.00 by Analysts at The Goldman Sachs Group
08 Oct 2024 11:01:11 By Buzz FX
-
Black Diamond Therapeutics (NASDAQ:BDTX) Given "Outperform" Rating at Wedbush
08 Oct 2024 11:01:11 By Buzz FX